89 related articles for article (PubMed ID: 17581372)
1. Myocardial reperfusion injury and the challenging quest for its prevention.
Merx MW; Kelm M
Crit Care Med; 2007 Jul; 35(7):1793-4. PubMed ID: 17581372
[No Abstract] [Full Text] [Related]
2. The fibrin-derived peptide Bbeta15-42 is cardioprotective in a pig model of myocardial ischemia-reperfusion injury.
Roesner JP; Petzelbauer P; Koch A; Mersmann J; Zacharowski PA; Boehm O; Reingruber S; Pasteiner W; Mascher D; Wolzt M; Barthuber C; Nöldge-Schomburg GE; Scheeren TW; Zacharowski K
Crit Care Med; 2007 Jul; 35(7):1730-5. PubMed ID: 17522584
[TBL] [Abstract][Full Text] [Related]
3. FX-06, a fibrin-derived Bbeta15-42 peptide for the potential treatment of reperfusion injury following myocardial infarction.
Ahrens I; Peter K
Curr Opin Investig Drugs; 2009 Sep; 10(9):997-1003. PubMed ID: 19705343
[TBL] [Abstract][Full Text] [Related]
4. The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury.
Petzelbauer P; Zacharowski PA; Miyazaki Y; Friedl P; Wickenhauser G; Castellino FJ; Gröger M; Wolff K; Zacharowski K
Nat Med; 2005 Mar; 11(3):298-304. PubMed ID: 15723073
[TBL] [Abstract][Full Text] [Related]
5. Hemorrhagic shock and reperfusion injury: the critical interplay of fibrin fragments, leukocytes, and vascular endothelial-cadherin.
Beishuizen A; Girbes AR
Crit Care Med; 2009 Feb; 37(2):771-2. PubMed ID: 19325382
[No Abstract] [Full Text] [Related]
6. Bbeta15-42 (FX06) reduces pulmonary, myocardial, liver, and small intestine damage in a pig model of hemorrhagic shock and reperfusion.
Roesner JP; Petzelbauer P; Koch A; Tran N; Iber T; Vagts DA; Scheeren TW; Vollmar B; Nöldge-Schomburg GE; Zacharowski K
Crit Care Med; 2009 Feb; 37(2):598-605. PubMed ID: 19114899
[TBL] [Abstract][Full Text] [Related]
7. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial.
Atar D; Petzelbauer P; Schwitter J; Huber K; Rensing B; Kasprzak JD; Butter C; Grip L; Hansen PR; Süselbeck T; Clemmensen PM; Marin-Galiano M; Geudelin B; Buser PT;
J Am Coll Cardiol; 2009 Feb; 53(8):720-9. PubMed ID: 19232907
[TBL] [Abstract][Full Text] [Related]
8. Increased inotropism following PARP inhibition in the setting of myocardial reperfusion injury: another piece in the jigsaw?
Rehberg S; Thiemermann C; Traber DL
Shock; 2010 Jun; 33(6):668-9. PubMed ID: 19789459
[No Abstract] [Full Text] [Related]
9. Fighting the "fire" of myocardial reperfusion injury: how to define success?
Wu KC
J Am Coll Cardiol; 2009 Feb; 53(8):730-1. PubMed ID: 19232908
[No Abstract] [Full Text] [Related]
10. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart.
Bliksøen M; Kaljusto ML; Vaage J; Stensløkken KO
Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926
[TBL] [Abstract][Full Text] [Related]
11. Letter by Tsikas and Rossi regarding article, "Nitrite anion provides potent cytoprotective and antiapoptotic effects as adjunctive therapy to reperfusion for acute myocardial infarction".
Tsikas D; Rossi R
Circulation; 2009 May; 119(19):e531; author reply e532. PubMed ID: 19451359
[No Abstract] [Full Text] [Related]
12. Hotline sessions of the 30th European Congress of Cardiology.
Atar D
Eur Heart J; 2009 May; 30(9):1151. PubMed ID: 19339265
[No Abstract] [Full Text] [Related]
13. Mast cell inhibition and reduced ventricular arrhythmias in a swine model of acute myocardial infarction upon therapeutic administration of relaxin.
Nistri S; Cinci L; Perna AM; Masini E; Bani D
Inflamm Res; 2008; 57 Suppl 1():S7-8. PubMed ID: 18345514
[No Abstract] [Full Text] [Related]
14. Carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
Xu X; Cao Z; Cao B; Li J; Guo L; Que L; Ha T; Chen Q; Li C; Li Y
Surgery; 2009 Sep; 146(3):506-14. PubMed ID: 19715808
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and bioactivity of substituted indan-1-ylideneaminoguanidine derivatives.
Zhang R; Dong J; Xu YG; Hua WY; Wen N; You QD
Eur J Med Chem; 2009 Sep; 44(9):3771-6. PubMed ID: 19482383
[TBL] [Abstract][Full Text] [Related]
16. Physiology and pharmacology of myocardial preconditioning and postconditioning.
Huffmyer J; Raphael J
Semin Cardiothorac Vasc Anesth; 2009 Mar; 13(1):5-18. PubMed ID: 19329471
[TBL] [Abstract][Full Text] [Related]
17. Anti-ischemic effects of inotropic agents in experimental right ventricular infarction.
Hein M; Roehl AB; Baumert JH; Scherer K; Steendijk P; Rossaint R
Acta Anaesthesiol Scand; 2009 Aug; 53(7):941-8. PubMed ID: 19426242
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin: ready for prime-time cardioprotection.
Riksen NP; Hausenloy DJ; Yellon DM
Trends Pharmacol Sci; 2008 May; 29(5):258-67. PubMed ID: 18359096
[TBL] [Abstract][Full Text] [Related]
19. [Effects of tongxinluo on mini-swine vascular endothelial integrity and myocardial no-reflow in early reperfusion of acute myocardial infarction].
Zhang HT; Yang YJ; Wu YL; Cheng YT; Kang S; Zhao JL; Meng L; Tian Y; Zhang YW; Ye J; Meng XM
Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1421-5. PubMed ID: 19671339
[TBL] [Abstract][Full Text] [Related]
20. Activation of sensory neurons reduces ischemia/reperfusion-induced acute renal injury in rats.
Mizutani A; Okajima K; Murakami K; Mizutani S; Kudo K; Uchino T; Kadoi Y; Noguchi T
Anesthesiology; 2009 Feb; 110(2):361-9. PubMed ID: 19194162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
